A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyrolidism

被引:69
作者
Boudou, P.
Ibrahim, F.
Cormier, C.
Sarfati, E.
Souberbielle, J. C.
机构
[1] St Louis Univ Hosp, Dept Hormonal Biol, AP HP, F-75475 Paris 10, France
[2] St Louis Univ Hosp, Dept Hormonal Biol, INSERM, U671, F-75475 Paris, France
[3] St Louis Univ Hosp, Dept Endocrine Surg, F-75475 Paris 10, France
[4] Hop Cochin, Dept Rhumatol, F-75674 Paris, France
[5] Hop Necker Enfants Malad, Physiol Lab, Assistance Publ, F-75674 Paris, France
[6] Hop Paris, AP HP, F-75674 Paris, France
[7] INSERM, U671, Paris, France
关键词
primary hyperparathyroidism; vitamin D; parathyroid hormone;
D O I
10.1007/BF03344140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the demonstration that vitamin D status might influence the clinical and biological expression of primary hyperparathyroidism (PHPT), a serum 25-hydroxy vitamin D (25-OHD) concentration of 50 nmol/l has been considered by an expert panel as the minimum level to be maintained in asymptomatic PHPT patients. Two yr after this recommendation, we aimed to evaluate the frequency of serum 25-OHD concentrations below this threshold in PHPT patients. In the present study, serum 25-OHD, second- and third-generation PTH, calcium, phosphate, magnesium, albumin and creatinine were measured in 72 out 145 consecutive PHPT patients operated on in our Endocrine Surgery Department, in whom blood samples were available before as well as two days after surgical intervention. Before surgery, the frequency of serum 25-OHD levels < 50 nmol/l ranged from 91.5 to 100% whatever the classification used to identify patients: whole group, symptomatic vs asymptomatic, patients with calcium levels > 3 vs < 3 mmol/l. 25-OHD concentrations correlated negatively with the weight of adenoma, PTH levels, and total calcium concentrations measured before surgery. Pre-operative PTH levels, whatever the assay used, and total calcium concentrations were positively and significantly correlated. Two days post-surgery, 13 patients were moderately hypocalcemic. Neither pre-surgery 25-OHD nor PTH, calcium or phosphorus level or adenoma weight were predictive of post-operative hypocalcemia. The dramatic frequency of low 25-OHD concentrations in our PHPT patients demonstrates that the above-mentioned recommendation is far from being applied in France despite evidence of worsening expression of PHPT with decreasing 25-OHD serum levels.
引用
收藏
页码:511 / 515
页数:5
相关论文
共 20 条
[1]  
Bilezikian JP, 2002, J BONE MINER RES, V17, pN2
[2]   Third- or second-generation parathyroid hormone assays: A remaining debate in the diagnosis of primary hyperparathyroidism [J].
Boudou, P ;
Ibrahim, F ;
Cormier, C ;
Chabas, C ;
Sarfati, E ;
Souberbielle, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12) :6370-6372
[3]   Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function [J].
Gao, P ;
Scheibel, S ;
D'Amour, P ;
John, MR ;
Rao, SD ;
Schmidt-Gayk, H ;
Cantor, TL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (04) :605-614
[4]   Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency [J].
Grey, A ;
Lucas, J ;
Horne, A ;
Gamble, G ;
Davidson, JS ;
Reid, IR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :2122-2126
[5]   Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol [J].
Heaney, RP ;
Davies, KM ;
Chen, TC ;
Holick, MF ;
Barger-Lux, MJ .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2003, 77 (01) :204-210
[6]   Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone [J].
Inaba, M ;
Nakatsuka, K ;
Imanishi, Y ;
Watanabe, M ;
Mamiya, Y ;
Ishimura, E ;
Nishizawa, Y .
CLINICAL CHEMISTRY, 2004, 50 (02) :385-390
[7]   Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism [J].
Kantorovich, V ;
Gacad, MA ;
Seeger, LL ;
Adams, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3541-3543
[8]   A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the multiple outcomes of raloxifene evaluation clinical trial [J].
Lips, P ;
Duong, T ;
Oleksik, A ;
Black, D ;
Cummings, S ;
Cox, D ;
Nickelsen, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1212-1221
[9]   PARATHYROID FUNCTION IN HUMAN VITAMIN-D DEFICIENCY AND VITAMIN-D DEFICIENCY IN PRIMARY HYPERPARATHYROIDISM [J].
LUMB, GA ;
STANBURY, SW .
AMERICAN JOURNAL OF MEDICINE, 1974, 56 (06) :833-839
[10]  
Mittendorf EA, 2004, AM SURGEON, V70, P114